Skip to main content

Table 3 Treatment outcomes at D28

From: Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso

 

Treatment outcome (No, %) [95 CI]

 

Rural area (n = 62)

Urban area (n = 55)

Total (n = 117)

ETF

0 (0%) [0–6%]

0 (0%) [0–6%]

0 (0%) [0–3%]

LCF

   

- Recrudescence

9 (15%) [7–26%]

11 (20%) [10–33%]

20 (17%) [11–25%]

- New infection

5 (8%) [3–18%]

7 (13%) [5–24%]

12 (10%) [5–17%]

- No genotyping results

2 (3%) [0–11%]

2 (4%) [0–13%]

4 (3%) [1–9%]

LPF

   

- Recrudescence

14 (23%) [13–35%]

5 (9%) [3–20%]

19 (16%) [10–24%]

- New infection

17 (27%) [17–40%]

14 (25%) [15–39%]

31 (26%) [19–35%]

- No genotyping results

2 (3%) [0–11%]

1 (2%) [0–10%]

3 (3%) [1–7%]

ACPR

13 (21%) [12–33%]

15 (27%) [16–41%]

28 (24%) [17–33%]

ACPR (PCR-corrected)

35 (56%) [43–69%]

36 (65%) [51–78%]

71 (61%) [51–70%]

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us